PMID: 37091Apr 17, 1979

The effect of rifampicin on norethisterone pharmacokinetics

European Journal of Clinical Pharmacology
D J BackE Smith

Abstract

The pharmacokinetics of norethisterone have been studied in 8 women during and one month after treatment with rifampicin (450--600 mg/day). Rifampicin caused a significant reduction in the A.U.C. of a single dose of 1 mg norethisterone from 37.8 +/- 13.1 to 21.9 +/- 5.9 ng/ml X h (p less than 0.01). The plasma norethisterone half life (beta-phase) was also reduced from 6.2 +/- 1.7 to 3.2 +/- 1.0 h (p less than 0.0025). In one additional woman on long term oral contraceptive therapy the 12 hour plasma norethisterone concentration was reduced by rifampicin from 12.3 ng/ml to 2.3 ng/ml. Rifampicin caused a significant increase in antipyrine clearance, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity but there was no significant correlations between changes in these indices of liver microsomal enzyme induction. There was a significant correlation between the percentage increase in antipyrine clearance and the percentage decrease in norethisterone A.U.C. during rifampicin. The changes in norethisterone pharmacokinetics during rifampicin therapy are compatible with the known enzyme inducing effect of rifampicin.

References

Oct 1, 1978·Clinical Pharmacology and Therapeutics·D J BackE Smith
Oct 1, 1978·Journal of Steroid Biochemistry·B K Park
Apr 1, 1977·Clinical Pharmacology and Therapeutics·D D BreimerE Richter
Aug 1, 1976·Clinical Pharmacology and Therapeutics·R L ChangA P Alvares
Sep 20, 1976·JAMA : the Journal of the American Medical Association·J L SkolnickW H Anderson
Oct 1, 1975·Annals of Internal Medicine·R A O'Reilly
Dec 1, 1969·The Journal of Clinical Investigation·E S Vesell, J G Page

Citations

Jan 1, 1988·European Journal of Clinical Pharmacology·E PeruccaE E Ohnhaus
Dec 1, 1991·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·M L Orme, D J Back
Jan 1, 1990·Pharmacology & Therapeutics·M Barry, J Feely
Nov 13, 2001·Obstetrics and Gynecology·B D DickinsonCouncil on Scientific Affairs, American Medical Association
Aug 1, 1988·Clinical and Experimental Pharmacology & Physiology·K MadhusudanaraoP Bahadur
Jun 1, 1983·Epilepsia·J Dana-Haeri, A Richens
Jul 12, 1980·British Medical Journal
Nov 24, 1998·Journal of Clinical Pharmacology·M LeBelP K Narang
Apr 10, 1999·Journal of Clinical Pharmacology·C M LoiA J Sedman
Jan 1, 1981·Drug Metabolism Reviews·M T Kenny, B Strates
Jan 5, 2011·The Journal of the Association of Nurses in AIDS Care : JANAC·Jane McCall, Laura Vicol
Jun 1, 1994·Journal of the American Academy of Dermatology·D M MillerR T Brodell
Mar 22, 2008·The Journal of Steroid Biochemistry and Molecular Biology·Tuomas KorhonenOlavi Pelkonen
Oct 1, 1985·British Journal of Clinical Pharmacology·L KayM Kristensen
Nov 1, 1982·British Journal of Clinical Pharmacology·B K Park
Jun 1, 1984·Contraception·A A GomaaA A Abdel Wareth
Nov 25, 2000·Obstetrics and Gynecology Clinics of North America·A M Kaunitz
Sep 1, 1980·Tubercle·G Acocella, R Conti
Jul 1, 1983·Contraception·S F GrimmerJ Tjia
Nov 14, 2017·BJOG : an International Journal of Obstetrics and Gynaecology·K B SimmonsK M Curtis
Jun 1, 2005·The Journal of Family Planning and Reproductive Health Care·Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit
Dec 24, 2008·Obstetrics and Gynecology·Catalin S Buhimschi, Carl P Weiner
Mar 29, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yang XuGary L Skiles
Jul 1, 1982·British Journal of Clinical Pharmacology·D J BackJ Tjia
May 1, 1986·Drug Intelligence & Clinical Pharmacy·P F D'Arcy
Aug 2, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Magang ShouGary L Skiles
Jan 27, 2019·Obstetrics and Gynecology·American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology

Related Concepts

Pyramidone
Drug Interactions
Enzyme Induction
Gamma-glutamyl transferase
Half-Life
Hydroxycorticosteroids
Norethindrone, (1 beta)-Isomer
Tubocin

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.